Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 14.
doi: 10.1007/s12035-024-04478-w. Online ahead of print.

SUMOylation and DeSUMOylation: Tug of War of Pain Signaling

Aida Calderon-Rivera  1 , Kimberly Gomez  1 , Erick J Rodríguez-Palma  1 , Rajesh Khanna  2   3
Affiliations
Review

SUMOylation and DeSUMOylation: Tug of War of Pain Signaling

Aida Calderon-Rivera et al. Mol Neurobiol. .

Abstract

SUMOylation is a post-translational modification that attaches a small ubiquitin-like modifier (SUMO) group to a target protein via SUMO ligases, while deSUMOylation refers to the removal of this SUMO group by sentrin-specific proteases (SENPs). Although the functions of these processes have been well described in the nucleus, the role of SUMOylation and deSUMOylation in regulating ion channels is emerging as a novel area of study. Despite this, their contributions to pain signaling remain less clear. Therefore, this review consolidates the current evidence on the link(s) between SUMOylation, deSUMOylation, and pain, with a specific focus on ion channels expressed in the sensory system. Additionally, we explore the role of SUMOylation in the expression and function of kinases, vesicle proteins, and transcription factors, which result in the modulation of certain ion channels contributing to pain. Altogether, this review aims to highlight the relationship between SUMOylation and deSUMOylation in the modulation of ion channels, ultimately exploring the potential therapeutic role of these processes in chronic pain.

Keywords: DeSUMOylation; Ion channels; Pain; SUMOylation.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Rice ASC, Smith BH, Blyth FM (2016) Pain and the global burden of disease. Pain 157(4):791–796. https://doi.org/10.1097/j.pain.0000000000000454 - DOI - PubMed
    1. Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson AH, Yarnitsky D, Freeman R, Truini A, Attal N, Finnerup NB, Eccleston C, Kalso E, Bennett DL, Dworkin RH, Raja SN (2017) Neuropathic pain. Nat Rev Dis Primers 3:17002. https://doi.org/10.1038/nrdp.2017.2 - DOI - PubMed - PMC
    1. Dib-Hajj SD, Waxman SG (2019) Sodium channels in human pain disorders: genetics and pharmacogenomics. Annu Rev Neurosci 42:87–106. https://doi.org/10.1146/annurev-neuro-070918-050144 - DOI - PubMed
    1. Laedermann CJ, Abriel H, Decosterd I (2015) Post-translational modifications of voltage-gated sodium channels in chronic pain syndromes. Front Pharmacol 6:263. https://doi.org/10.3389/fphar.2015.00263 - DOI - PubMed - PMC
    1. Cai S, Gomez K, Moutal A, Khanna R (2021) Targeting T-type/CaV3.2 channels for chronic pain. Transl Res 234:20–30. https://doi.org/10.1016/j.trsl.2021.01.002 - DOI - PubMed - PMC

LinkOut - more resources